- Republic of Korea update
- Shelf-life for AccruferÂ® extended to 48 months
- Data presented at ACG Annual Scientific Meeting
- Block Listing 6 Monthly Return
- Holding(s) in Company
- Half-year Report
- Launch of new corporate brand and website
- Total Voting Rights Update
- Notice of Interim Results
- Grant of share options
Shield Therapeutics PLC (1JS:FRA) closed at 0.072, 38.46% above the 52 week low of 0.052 set on Jul 22, 2022.
0.052Jul 22 20220.540Jan 06 2022
|Market cap||18.66m GBP|
|EPS (TTM)||-0.1079 |
Data delayed at least 15 minutes, as of Dec 02 2022 07:01 GMT.